Intermediate

Cutaneous Lesion Screening Protocol in Elderly Populations

A standardized, systematic approach to cutaneous examination and referral in elderly patients, with a documentation instrument designed for multidisciplinary teams.

16 estimated instructional hours Professionals in geriatric, long-term care, or primary-care settings Online / remote
Why this course

Needs & context

Skin cancer is the most common malignancy in the United States, with incidence rising sharply after age 65. Elderly patients in long-term care have limited access to dermatological screening, and non-dermatologist professionals lack standardized tools for systematic cutaneous examination.

Learning objectives

Upon completion, the participant will be able to:

  • Identify the epidemiological burden of cutaneous lesions in the elderly and apply risk-stratification criteria.
  • Demonstrate a systematic dermatological examination sequence appropriate for elderly patients.
  • Apply suspicion parameters to differentiate benign, pre-malignant and malignant lesions.
  • Select appropriate referral criteria for dermatology specialist consultation.
  • Use the standardized recording instrument to document findings and support team communication.
  • Adapt the screening protocol to the institutional context of contracting facilities.

Topics covered

  • Epidemiology of cutaneous lesions in the elderly: prevalence, underdiagnosis, mortality data
  • Risk-stratification criteria for geriatric populations
  • Systematic dermatological examination sequence
  • Suspicion parameters (ABCDE rule, ugly-duckling sign)
  • Referral criteria to dermatology specialists
  • Standardized recording instrument for multidisciplinary teams
  • Protocol adaptation per contracting institution
  • Online post-assessment (10 questions, 70% to complete) and participant evaluation

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.
  2. Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S. Am J Prev Med. 2015;48(2):183-187.
  3. Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674.
  4. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal and squamous cell carcinomas. JAMA. 2005;294(6):681-690.
  5. Dessinioti C, Tzannis K, Sypsa V, et al. Epidemiological and clinical predictors of actinic keratosis. Br J Dermatol. 2017;177(5):1365-1372.

Modality & credit. Delivered fully online/remotely. Upon completion of the post-assessment, participants receive a certificate of completion stating the estimated instructional hours. This certificate is not an accredited continuing-education credit — no ANCC, AMA, ACCME, Florida Board of Nursing or other state-board credit is offered or implied.

Scope. This course provides education in technique and clinical knowledge. Clinical application is subject to each participant's licensure, scope of practice, and state regulations.

Instructor disclosure. Leonardo Bianchini, MD (Brazil), PhD, RN — declares no relevant financial relationships with commercial interests related to the content of these educational activities. No commercial support was received for any course.